View printer-friendly version
« Back
May 08, 2015 2:08 p.m.
Teva to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

JERUSALEM--(BUSINESS WIRE)--May 8, 2015-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the Bank of America Merrill Lynch 2015 Health Care Conference. Eyal Desheh, Group EVP & CFO will present on Wednesday, May 13, 2015 at 3:40 PM PT.

What: Teva Presentation at the Bank of America Merrill Lynch Healthcare Conference
Who: Eyal Desheh, Group EVP and CFO,
Teva Pharmaceutical Industries Ltd.
When: Wednesday, May 13, 2015
How: Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website .

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit

Source: Teva Pharmaceutical Industries Ltd.

IR Contacts:
Kevin C. Mannix, (215) 591-8912
United States
Ran Meir, (215) 591-3033
United States
Tomer Amitai, 972 (3) 926-7656
PR Contacts:
Iris Beck Codner, 972 (3) 926-7246
Denise Bradley, (215) 591-8974
United States